{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:09:05Z","timestamp":1785150545463,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ihj.2021.02.010","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T17:16:01Z","timestamp":1613582161000},"page":"372-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8204-6533","authenticated-orcid":false,"given":"Basil","family":"John","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-9912","authenticated-orcid":false,"given":"Mariya","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2959-3685","authenticated-orcid":false,"given":"Sandramol","family":"shaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suja","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jabir","family":"Abdullakutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ihj.2021.02.010_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.CIR.0000085166.44904.79","article-title":"Natural history of asymptomatic left ventricular systolic dysfunction in the community","volume":"108","author":"Wang","year":"2003","journal-title":"Circulation"},{"issue":"27","key":"10.1016\/j.ihj.2021.02.010_bib2","first-page":"2180","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ihj.2021.02.010_bib3","first-page":"227","article-title":"Levosimendan: current data, clinical use and future development","volume":"5","author":"Nieminen","year":"2013","journal-title":"Heart Lung Vessel"},{"issue":"1","key":"10.1016\/j.ihj.2021.02.010_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00000539-200001000-00003","article-title":"Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of KATP channels","volume":"90","author":"Kersten","year":"2000","journal-title":"Anesth Analg"},{"issue":"17","key":"10.1016\/j.ihj.2021.02.010_bib5","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.ihj.2021.02.010_bib6","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial","volume":"360","author":"Follath","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ihj.2021.02.010_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1755-5922.2008.00050.x","article-title":"Levosimendanversus Dobutamine in heart failure subjects treated chronically with carvedilol","volume":"26","author":"Duygu","year":"2008","journal-title":"Cardiovasc Therapeut"},{"issue":"16","key":"10.1016\/j.ihj.2021.02.010_bib8","doi-asserted-by":"crossref","first-page":"C168","DOI":"10.1016\/j.jacc.2016.07.632","article-title":"GW27-e0351. The efficacy analysis between Levosimendan and dobutamine on post cardiac surgery patients","volume":"68","author":"Jieyu","year":"2016","journal-title":"JACC (J Am Coll Cardiol)"},{"issue":"4","key":"10.1016\/j.ihj.2021.02.010_bib9","first-page":"338","article-title":"Hemodynamic effects of Levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery","volume":"59","author":"Alvarez","year":"2006","journal-title":"Rev Esp Cardiol"},{"issue":"1","key":"10.1016\/j.ihj.2021.02.010_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5603\/CJ.a2014.0044","article-title":"Assessment of sustained effects of Levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure","volume":"22","author":"Oner","year":"2015","journal-title":"Cardiol J"},{"issue":"3","key":"10.1016\/j.ihj.2021.02.010_bib11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.jvca.2013.09.004","article-title":"Levosimendan improves renal outcome in cardiac surgery: a randomised trial","volume":"28","author":"Baysal","year":"2014","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"2","key":"10.1016\/j.ihj.2021.02.010_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4103\/aca.ACA_195_16","article-title":"Comparison of Levosimendan versus Dobutamine in patients with moderate to severe left ventricular dysfunction undergoing off-pump coronary artery bypass grafting: a randomised prospective study","volume":"20","author":"Kandasamy","year":"2017","journal-title":"Ann Card Anesthesia"},{"issue":"9","key":"10.1016\/j.ihj.2021.02.010_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.repc.2017.03.006","article-title":"Inotropes and cardiorenal syndrome in acute heart failure- A retrospective comparative analysis","volume":"36","author":"Madeira","year":"2017","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.ihj.2021.02.010_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijcard.2008.10.003","article-title":"Plasma B- type natriuretic peptide reduction predicts long term response to Levosimendan therapy in acute decompensated chronic heart failure","volume":"139","author":"Farmakis","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ihj.2021.02.010_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","article-title":"Effect of Levosimendan on short term clinical course of patients with acute decompensated heart failure","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483221000511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483221000511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:54:47Z","timestamp":1758081287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483221000511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0019483221000511"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2021.02.010","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes of levosimendan versus dobutamine in patients with acute decompensated heart failure with reduced ejection fraction and impaired renal function","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2021.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Cardiological Society of India. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}